Telemus Capital’s Strata Skin Sciences SSKN Stock Holding History

Telemus Capital’s Portfolio SSKN Stock Details SSKN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-30	Closed	–	–	537
2017 Q4	$0	Buy	+30	New	+$419	﹤0.01%	608

Other funds holding SSKN

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Telemus Capital's SSKN Position: Q1 2018 in Review

Telemus Capital sold out of Strata Skin Sciences (SSKN) in Q1 2018, closing a stake of 30 shares.

Telemus Capital first reported a position in SSKN in Q4 2017 and held it in 1 quarter. The position peaked at $0 in Q4 2017. 16 funds tracked by Wall St. Rank hold SSKN as of Q1 2018.

Telemus Capital reported no remaining Strata Skin Sciences position as of Q1 2018 after selling out during the quarter.
Telemus Capital sold 30 Strata Skin Sciences shares in Q1 2018.
Telemus Capital first reported a position in Strata Skin Sciences in Q4 2017 and held it in 1 quarter.
Telemus Capital's Strata Skin Sciences position peaked at $0 in Q4 2017.
16 funds tracked by Wall St. Rank held Strata Skin Sciences as of Q1 2018.

Based on Telemus Capital's 13F filing for Q1 2018, filed 27 Apr 2018.